Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Product revenue	$ 2,311	$ 1,083	$ 6,778	$ 3,653
Operating costs and expenses:
Cost of product revenue	875	620	2,651	1,938
Unfunded research and product development expenses	301	327	948	1,037
Selling, general and administrative expenses	880	1,308	2,626	3,378
Operating income (loss)	255	(1,172)	553	(2,700)
Other Income (Expense), Net	4	(7)	13	176
Income (loss) before income taxes and non-controlling interest	259	(1,179)	566	(2,524)
Income tax expense	(113)	(6)	(268)	(6)
Net income (loss)	146	(1,185)	298	(2,530)
Plus: Net loss (income) attributed to non-controlling interest	18	36	52	(10)
Net income (loss) attributed to MTI	$ 164	$ (1,149)	$ 350	$ (2,540)
Income (loss) per share attributable to MTI (Basic) (in dollars per share)	$ 0.03	$ (0.22)	$ 0.07	$ (0.48)
Income (loss) per share attributable to MTI (Diluted) (in dollars per share)	$ 0.03	$ (0.22)	$ 0.07	$ (0.48)
Weighted average shares outstanding (Basic) (in shares)	5,256,883	5,256,883	5,256,883	5,256,007
Weighted average shares outstanding (Diluted) (in shares)	5,387,660	5,256,883	5,275,971	5,256,007